Practice Location

701 SUPERIOR AVE
MUNSTER, IN 46321-4037

Phone: (219) 934-0150

What does LARRY WOLFF research?

Dr. Wolff's research encompasses a range of health topics. He investigates how cancer treatments like immune checkpoint inhibitors may trigger side effects such as sarcoidosis and hemophilia. His work also extends to studying long-term symptoms in patients recovering from COVID-19, aiming to understand how these can affect quality of life. Additionally, he explores safe sedation methods for children undergoing medical procedures and evaluates at-home ultrasound technologies for monitoring pregnancies. This combination of studies contributes to improving patient care across different medical fields.

Key findings

  • In his study on immune checkpoint inhibitors and sarcoidosis, only 19.6% of 43 patients experienced flare-ups, mostly manageable with corticosteroids.
  • Research on post-COVID-19 syndrome aims to document changes in symptoms and quality of life and could help in improving treatment for recovering patients.
  • A study on home vaginal ultrasound devices found over 80% correlation with in-clinic scans, indicating they can reliably monitor ovarian stimulation in fertility treatments.
  • Among patients receiving immune checkpoint inhibitors, 30% exhibited severe complications from induced large vessel vasculitis, with most improving after treatment.
  • In his analysis of neuroendocrine tumors, NET G3 patients had an average overall survival rate of 43.9 months, significantly better than the 12.7 months for those with neuroendocrine carcinoma.

Frequently asked questions

Does Dr. Wolff study cancer treatments?
Yes, he researches the effects of immune checkpoint inhibitors and other cancer treatments on patients, including side effects and outcomes.
What are the implications of Dr. Wolff's work on post-COVID syndrome?
His studies aim to clarify the long-term health issues faced by COVID-19 survivors, which can improve treatment options for those affected.
Are Dr. Wolff's findings relevant for patients undergoing fertility treatments?
Absolutely. His research on home ultrasound devices has shown that they can be a safe and effective alternative for monitoring during fertility treatments.
What insights does Dr. Wolff provide for parents with children undergoing procedures?
He investigates the best techniques for pediatric sedation, ensuring children remain calm and comfortable during medical procedures.
How does Dr. Wolff's research impact stroke patients?
His work on treatment effectiveness for stroke patients helps doctors choose the best strategies based on blood supply conditions in the brain.

Publications in plain English

Tools, Techniques, and Medications for Procedural Sedation in Children.

2026

Pediatric annals

Ali HM, Wolff L, Said SJ, Holbrook JS

Plain English
This study looks at the different methods and medications used for safely sedating children during medical procedures. The authors highlight various approaches, including preparation techniques, distractions, and different types of sedatives, to create effective and tailored sedation plans. Understanding these options is important because it helps healthcare providers choose the best strategies to keep children calm and comfortable during treatments. Who this helps: This helps doctors and healthcare providers who work with children during medical procedures.

PubMed

Systematic review and meta-analysis assessing longitudinal changes in symptom prevalence, severity and health-related quality of life in post-COVID-19 syndrome: a protocol.

2026

BMJ open

Sarpari K, Thölking T, Röver C, Ammous O, Müller F +5 more

Plain English
This study looks at ongoing health issues faced by adults who have had COVID-19, known as post-COVID-19 syndrome (PCS), which includes symptoms like tiredness, breathing difficulties, depression, and sleep disturbances that last for more than four weeks after the initial infection. The researchers plan to combine results from various studies to see how these symptoms change over time and how they affect people's quality of life. Understanding these changes will help identify how many people are still suffering and the severity of their symptoms, which is crucial for improving treatment options. Who this helps: This benefits patients recovering from COVID-19 and healthcare providers looking to offer better support.

PubMed

When immunity backfires: Meta-analysis on sarcoidosis reactivation in cancer patients treated with immune checkpoint inhibitors.

2026

Critical reviews in oncology/hematology

Martella S, Cusumano G, Stylianakis D, Wolff L, Porcu M +8 more

Plain English
This study examined how often sarcoidosis, a condition that can affect various organs, becomes active again in cancer patients receiving immune checkpoint inhibitors (ICIs), a type of cancer treatment. Of the 43 cancer patients with existing sarcoidosis treated with ICIs, only 19.6% experienced a flare-up, and most of these flares were mild to moderate, manageable with corticosteroids, and did not require ending cancer treatment. This matters because it shows that, while there is a risk of sarcoidosis flare, it is generally low and manageable in patients undergoing ICI therapy. Who this helps: This information helps patients with pre-existing sarcoidosis who are considering immune checkpoint inhibitors for cancer treatment.

PubMed

Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndrome.

2026

Leukemia

Zhao LP, Kosmider O, Heiblig M, Moulinet T, Lacombe V +22 more

PubMed

Label refinement network from synthetic error augmentation for medical image segmentation.

2025

Medical image analysis

Chen S, Garcia-Uceda A, Su J, van Tulder G, Wolff L +2 more

Plain English
This study focused on improving the way computers interpret and segment images of medical structures, like airways and blood vessels, in scans. Researchers developed a new method to fix errors in image segmentations that made them look incorrect, achieving better results by training their model with synthetic examples of errors. Their approach outperformed standard methods, showing improvements of up to 15% in segmentation accuracy. Who this helps: This helps doctors and medical professionals by providing clearer and more accurate images for diagnosis and treatment planning.

PubMed

Fetal Heart Rate and Amniotic Fluid Volume Measurements with a Home Ultrasound Device.

2025

American journal of perinatology

Pardo A, Nahum Fridland S, Rak OL, Klochendler Frishman E, Zafrir Danieli H +7 more

Plain English
This study looked at a home ultrasound device called Pulsenmore ES that allows expectant mothers to check their baby's heart rate and the amount of amniotic fluid using their smartphones. The results showed that when guided by a doctor, the device was around 96% accurate for heart rate measurements and 95% for fluid measurements. Even when used on their own, mothers were able to get heart rate readings that were about 6 beats per minute off from standard clinic readings, which is still pretty close. Who this helps: This benefits pregnant women who want to monitor their baby's health more conveniently from home.

PubMed

Patterns and outcomes of current antitumor therapy for high-grade neuroendocrine neoplasms: perspective of a tertiary referral center.

2025

Journal of cancer research and clinical oncology

Melhorn P, Spitzer J, Adel T, Wolff L, Mazal P +2 more

Plain English
This study examined the treatment outcomes for patients with advanced high-grade neuroendocrine tumors, specifically focusing on two types: neuroendocrine carcinomas (NEC) and neuroendocrine tumors grade 3 (NET G3). Researchers analyzed 80 patients and found that those with NET G3 had better survival rates, with an average progression-free survival of 16.1 months and overall survival of 43.9 months, compared to only 6.1 months for progression-free survival and 12.7 months for overall survival in NEC patients. These findings are important because they help clarify how different treatments perform for these challenging cancer types, guiding doctors in choosing the best options for their patients. Who this helps: This helps doctors and patients facing advanced neuroendocrine tumors.

PubMed

Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study.

2025

Rheumatology (Oxford, England)

Cottu A, Delaval L, Forestier A, Tomelleri A, Campochiaro C +24 more

Plain English
This study looked at a rare side effect called large vessel vasculitis (LVV) that can happen in patients receiving a type of cancer treatment known as immune checkpoint inhibitors (ICIs). Among 27 patients analyzed, the average age was 68, and about 30% were treated with a combination of two specific drugs. The findings showed that while many symptoms were similar to those seen in patients with primary LVV, the diagnosis process and certain complications, such as vision loss, occurred more frequently in those with ICI-induced LVV. Most patients improved with treatment, but the risk of death was mainly due to cancer rather than the vasculitis itself. Who this helps: This information helps patients undergoing cancer treatment and their doctors by clarifying potential risks and management strategies.

PubMed

Cognitive benefits of music in aerobic exercise: Evidence from a Bayesian network meta-analysis in adults with mild cognitive impairment.

2025

Archives of gerontology and geriatrics

Quan Y, Lo CY, Wolff L, Wang J, Olsen KN +1 more

Plain English
This study looked at how different types of exercise—specifically aerobic exercise with music, aerobic exercise without music, and dance—affect cognitive function in older adults with mild cognitive impairment (MCI). Researchers found that aerobic exercise with music had the most significant positive impact on overall thinking skills, with an improvement score of 1.2, compared to 0.48 for exercise without music and 0.55 for dance. The findings highlight that adding music to exercise can enhance brain function even further, suggesting a powerful combination for helping those with MCI. Who this helps: This benefits older adults with mild cognitive impairment and their caregivers.

PubMed

Arterial collateral status and treatment effect of intravenous alteplase thrombolysis prior to endovascular treatment in patients with anterior circulation large vessel occlusion: prespecified analysis of the MR CLEAN-NO IV trial.

2025

Journal of neurointerventional surgery

Yang W, Cavalcante F, Treurniet KM, Kappelhof M, Bruggeman AAE +16 more

Plain English
This study looked at how the blood supply in the brain affects the success of a specific stroke treatment—intravenous alteplase (IVT)—when combined with endovascular treatment (EVT). Researchers analyzed data from 526 patients and found that using IVT did not significantly improve outcomes compared to EVT alone, with a slight odds ratio of 1.14, meaning the treatment didn't work better even when accounting for blood supply conditions in the brain. This is important because it indicates that the state of collateral blood flow does not help in deciding treatment strategies for acute ischemic stroke patients. Who this helps: This helps doctors in choosing the best treatment for stroke patients.

PubMed

C-terminal binding protein 2 interacts with JUNB to control macrophage inflammation.

2025

Life science alliance

Strickland BA, Babl A, Wolff L, Singh P, Friano ME +2 more

Plain English
This study looked at how a protein called CTBP2 affects inflammation in immune cells known as macrophages. Researchers found that CTBP2 helps control inflammation by working with other proteins to switch off inflammatory genes, while a different form of this protein (the monomer) does not have this ability. This is important because understanding how CTBP2 works could lead to new treatments for chronic inflammatory diseases that are responsible for many health problems. Who this helps: This helps patients with chronic inflammatory diseases.

PubMed

Nephrogenic Diabetes Insipidus Associated with Temozolomide Therapy in a Patient with Grade IV Astrocytoma.

2025

European journal of case reports in internal medicine

Fargouche Z, Manderlier M, Meert AP, Wolff L, Ilzkovitz M

Plain English
This study examined a rare side effect of the cancer drug temozolomide in a 45-year-old man with a severe brain tumor. The patient developed nephrogenic diabetes insipidus, which caused excessive urination and high sodium levels, after starting temozolomide. Recovering from this condition took a while even after stopping the medication, highlighting the importance of monitoring kidney function in patients taking this drug. Who this helps: This information benefits patients with brain tumors who may be treated with temozolomide, as well as their doctors.

PubMed

Retrospective cohort of prenatal home ultrasound utilization and maternal-neonatal outcomes.

2025

BMC pregnancy and childbirth

Pardo A, Kalafat E, Hazon S, Pailis M, Klochendler-Frishman E +10 more

Plain English
This study looked at the use of a handheld home ultrasound device by pregnant women to monitor their babies, comparing those who used the device to those who did not. It found that among 4,460 women using the device and 102,707 who did not, there were no significant differences in preterm birth rates or any other negative outcomes for mothers or babies. This is important because it shows that using this home ultrasound is safe and can provide peace of mind without posing risks to pregnancy or neonatal health. Who this helps: This benefits pregnant women and their healthcare providers.

PubMed

Monitoring Ovarian Stimulation for Assisted Reproduction With Patient Self-Scans Using a Home Vaginal Ultrasound Device: A Single-Center Interventional, Prospective Study.

2025

Journal of medical Internet research

Shufaro Y, Cohen M, Wertheimer A, Altman E, Wolff L +3 more

Plain English
This study looked at whether a home vaginal ultrasound device could reliably monitor ovarian stimulation in women undergoing fertility treatments, comparing its results to traditional in-clinic scans. Out of 34 women participating, the data showed that measurements of follicle counts and endometrial thickness from home scans were very similar to those from in-clinic scans, with correlation rates over 80%. The findings matter because they suggest that using this home device could make the monitoring process easier and more convenient for patients without compromising accuracy. Who this helps: This benefits patients undergoing fertility treatments.

PubMed

Acquired hemophilia due to immune checkpoint inhibitors: a case series introducing emicizumab treatment.

2025

The oncologist

Wolff L, Ertl C, Heinzerling L, Aspeslagh S, Verhaert M +4 more

Plain English
This study looked at 11 patients in Belgium who developed a rare bleeding disorder called acquired hemophilia A after being treated with immune checkpoint inhibitors for cancer. Most patients were around 68 years old, and 9 out of 11 were treated successfully with immunosuppressive therapy, resolving their condition. For the first time, one patient was treated with emicizumab, which simplifies treatment and reduces the need for other immune-suppressing drugs. Who this helps: This research benefits patients receiving immune checkpoint inhibitors and their doctors, as it provides new treatment options for severe side effects.

PubMed

Rethinking Matrigel: The Complex Journey to Matrix Alternatives in Organoid Culture.

2025

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Wolff L, Hendrix S

Plain English
This study looks at Matrigel, a common substance used to support cell cultures in organoid research. While it effectively mimics the environment that cells need to grow, it has drawbacks, including being variable, derived from animals, and not always applicable to human biology. Researchers found that these issues often limit progress in developing better alternatives, so they recommend a more tailored approach when choosing or creating new supportive materials for different types of cell cultures. Who this helps: This helps researchers and scientists working on human organoid cultures.

PubMed

Neural Correlates of Chanting: A Systematic Review.

2025

Wiley interdisciplinary reviews. Cognitive science

Perry G, Wolff L, Powers N, Thompson WF, Baumann O

Plain English
This research reviewed studies about chanting, a practice where people repeat sounds or phrases. The analysis found that chanting activates specific brain areas linked to attention and emotions, showing that it reduces distracting thoughts and encourages relaxation. In particular, chanting increased activity in brain areas like the prefrontal cortex and decreased activity in areas involved in self-referential thinking, with EEG results showing more brain waves associated with relaxation. Who this helps: This helps patients and anyone interested in mindfulness and mental health therapies.

PubMed

Genome-scale transcriptome augmentation during Arabidopsis thaliana photomorphogenesis.

2025

Nature communications

Schivre G, Wolff L, Mirasole FM, Vidal A, Davidson MLH +7 more

Plain English
This study looked at how light affects gene activity in the plant Arabidopsis thaliana. Researchers found that when exposed to light, 94% of the analyzed genes were turned on within the first six hours, leading to a doubling of gene activity in the plants. This is important because it helps scientists understand how plants respond to light and could lead to better methods for studying plant growth and adaptation. Who this helps: This supports researchers and farmers working to improve crop yields and plant development.

PubMed

The Impact of Prostate Volume in Open Radical Prostatectomy: A Single Centre Experience.

2024

Clinical genitourinary cancer

Stankovic M, Wolff L

Plain English
This study looked at how the size of the prostate affects the surgery results for men undergoing open radical prostatectomy. Researchers reviewed 909 cases and found that while larger prostates (over 70cc) had higher rates of urinary leakage and complications, the overall survival rates and cancer recurrence were similar across all prostate sizes. This is important because it confirms that surgery can still be an effective option for men with larger prostates despite some increased risks. Who this helps: This benefits patients with larger prostates considering prostate surgery.

PubMed

Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center.

2024

Clinical & experimental metastasis

Popov P, Steindl A, Wolff L, Bergen ES, Eckert F +7 more

Plain English
This study looked at patients with a specific type of lung cancer called large cell neuroendocrine carcinoma (LCNEC) that has spread to the brain. Out of over 6,000 patients, only 52 had both LCNEC and confirmed brain metastases, and the average survival time after being diagnosed with brain metastases was just 7 months. This is important because it shows these patients face a very poor outlook, particularly if their brain metastases occur at the same time as their cancer diagnosis. Who this helps: This helps patients with lung cancer, particularly those diagnosed with LCNEC and brain metastases, as well as their doctors.

PubMed

Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms.

2024

Endocrine-related cancer

Melhorn P, Mazal P, Wolff L, Popov P, Kretschmer-Chott E +4 more

Plain English
This study looked at a specific chemotherapy treatment called capecitabine/temozolomide (CAPTEM) for patients with neuroendocrine tumors (NET). Researchers found that using this treatment simultaneously for the first time resulted in a median progression-free survival of 13.3 months and an overall survival of 31.9 months. Additionally, 38.9% of patients showed a partial response to the treatment, and the safety of this approach was good, with no severe side effects reported. Who this helps: This benefits patients with neuroendocrine tumors, especially those whose treatment options have been limited.

PubMed

The UBP5 histone H2A deubiquitinase counteracts PRCs-mediated repression to regulate Arabidopsis development.

2024

Nature communications

Godwin J, Govindasamy M, Nedounsejian K, March E, Halton R +9 more

Plain English
This study investigated how a protein called UBP5 influences plant development by interacting with Polycomb Repressive Complexes (PRCs), which are responsible for turning off certain genes. The researchers found that UBP5 helps remove specific chemical markers (H2Aub and H3K27me3) that PRCs use to silence genes in the plant Arabidopsis thaliana. By doing this, UBP5 allows genes to be turned back on, which is important for proper plant growth and development. Who this helps: This benefits plant scientists and breeders working to improve crop development and resilience.

PubMed

The more the merrier? Evidence and efficacy of immune checkpoint- and tyrosine kinase inhibitor combinations in advanced solid cancers.

2024

Cancer treatment reviews

Starzer AM, Wolff L, Popov P, Kiesewetter B, Preusser M +1 more

Plain English
This study looks at the use of two types of cancer treatments—immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs)—when given together. Researchers found that while these combinations can be more effective, they also tend to cause more side effects compared to using either treatment alone. Specifically, some combinations like nivolumab with cabozantinib and pembrolizumab with axitinib have been approved for advanced kidney cancer and certain other cancers, but some combinations are so toxic that trials had to be stopped. Who this helps: This benefits cancer patients who may have access to more effective treatment options.

PubMed

From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms.

2024

Therapeutic advances in medical oncology

Melhorn P, Mazal P, Wolff L, Kretschmer-Chott E, Raderer M +1 more

Plain English
This study looked at how somatostatin analogs, like octreotide and lanreotide, can slow the growth of neuroendocrine tumors (NET), which are rare types of cancer. The research highlights that these drugs have proven effective in reducing tumor growth over the past 30 years, particularly noted in key studies where about 65% of patients showed significant benefits from treatment. This is important because managing NET improves patients' lives and offers better treatment options for this challenging cancer type. Who this helps: Patients with neuroendocrine tumors.

PubMed

The TELOMERE REPEAT BINDING proteins TRB4 and TRB5 function as transcriptional activators of PRC2-controlled genes to regulate plant development.

2024

Plant communications

Amiard S, Feit L, Vanrobays E, Simon L, Le Goff S +7 more

Plain English
Researchers studied two proteins, TRB4 and TRB5, in plants that help regulate gene expression related to how plants grow and respond to their environment. They found that TRB4 connects with a protein complex that affects hundreds of genes, including important ones for flowering, showing it's crucial for plant development. This matters because understanding these proteins could lead to better ways to manage plant growth and improve agricultural practices. Who this helps: This helps farmers and agricultural scientists seeking to enhance crop yields and resilience.

PubMed

[Not Available].

2024

La Revue de medecine interne

Wolff L, Khzouri T

PubMed

Retrospective Long-Term Evaluation of Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma over 20 Years.

2024

Cancers

Vogl TJ, Adwan H, Wolff L, Lahrsow M, Gruber-Rouh T +4 more

Plain English
This study looked at the long-term effects of a treatment called transarterial chemoembolization (TACE) for liver cancer in 836 patients over 20 years. It found that the average survival time for patients was about 700 days, with those treated with the aim of curing their cancer living the longest at around 790 days. Two factors, portal vein thrombosis and a poor liver function rating (Child-Pugh class B or worse), were linked to shorter survival times. Who this helps: This research benefits patients with liver cancer and their doctors by helping them understand treatment outcomes and risks better.

PubMed

MAGnetic REtriaval Device for Minimally Invasive Ureter Stent Removal.

2024

Journal of endourology

Stankovic M, Wolff L, Wieder T, Mendes J, Schumacher B

Plain English
This study looked at the effectiveness and pain levels of two methods for removing ureteral stents in patients undergoing kidney stone treatment, comparing traditional stents to new magnetic ones. It found that the magnetic stents took less time to remove—around 35 seconds quicker—and caused less pain, with an average pain rating of 2 compared to 6 for traditional stents. This is important because it shows that magnetic stents can provide a quicker, less painful option for patients, improving their overall experience and reducing healthcare costs. Who this helps: Patients needing ureteral stent removal for kidney stones.

PubMed

CLUH maintains functional mitochondria and translation in motoneuronal axons and prevents peripheral neuropathy.

2024

Science advances

Zaninello M, Schlegel T, Nolte H, Pirzada M, Savino E +10 more

Plain English
This study looked at a protein called CLUH that helps transport and translate important messages needed for energy production in nerve cells. Researchers found that when CLUH was missing in mice, it caused problems like nerve damage and movement difficulties. They discovered that boosting another protein, ABCE1, could fix some of the issues caused by the absence of CLUH, helping the nerve cells to grow properly and maintain their function. Who this helps: This research benefits patients with peripheral neuropathy and motor disorders.

PubMed

A case of VEXAS with microcytic anemia: don't be mislead by an associated condition!

2024

Acta clinica Belgica

Squalli K, Wolff L, Vandergheynst F

Plain English
This study looked at a rare condition called VEXAS syndrome in a 61-year-old man who had both low red blood cell counts and various symptoms like skin lesions and frequent fevers. Despite his anemia being usually linked to another condition called beta-thalassemia, tests revealed he actually had VEXAS syndrome, which was confirmed by a specific genetic mutation. This finding is important because it highlights that doctors should still consider VEXAS syndrome even when patients present with a different type of anemia, especially in areas where thalassemia is common. Who this helps: This helps doctors diagnose VEXAS syndrome in patients who may have unexpected symptoms or anemia types.

PubMed

[What should be done in case of cutaneous sclerosis?].

2024

Revue medicale suisse

Wolff L, Maniu CM, Orte Cano C, Fossati C, Bart PA

Plain English
This research paper looks at cutaneous sclerosis, a condition where the skin becomes thick and hard. It often occurs with systemic sclerosis but can also appear in other rare syndromes. The study discusses the causes, symptoms, and treatments for these conditions, highlighting their wide variety and complexity. Who this helps: Patients with cutaneous sclerosis and their doctors.

PubMed

Understanding Myelodysplasia and Inflammation Through the Lense of VEXAS Syndrome: A Review.

2024

Cells

Wolff L, Caratsch L, Zhao LP, Blum S, Comte D

Plain English
This study reviewed VEXAS syndrome, a genetic disorder linked to inflammation and blood disorders, particularly myelodysplastic syndromes. It was found that 10% to 30% of patients with myelodysplastic syndromes also show signs of systemic inflammatory diseases, which is much higher than the 5% seen in the general population. Understanding how VEXAS and inflammation are connected can help develop new treatments and diagnostic methods for these blood-related diseases. Who this helps: This helps patients with myelodysplastic syndromes and doctors treating them.

PubMed

VEXAS syndrome: a Swiss national retrospective cohort study.

2024

Swiss medical weekly

Wolff L, Caratsch L, Lötscher F, Seitz L, Seitz P +17 more

Plain English
This study investigated VEXAS syndrome, a rare inflammatory condition linked to a genetic mutation in the UBA1 gene, among Swiss patients. Researchers found 23 patients, mostly men, who exhibited various symptoms like skin rashes (88%), general fatigue (82%), and blood clots (59%), with all patients showing macrocytic anemia at some point. Treatments such as ruxolitinib and azacytidine proved effective, with a 100% positive response rate for those treated. Who this helps: This research benefits patients with VEXAS syndrome by providing insights into effective treatment options.

PubMed

Time dependency of automated collateral scores in computed tomography angiography and computed tomography perfusion images in patients with intracranial arterial occlusion.

2023

Neuroradiology

Su J, Wolff L, van Doormaal PJ, Dippel DWJ, van Zwam W +3 more

Plain English
This study looked at how the timing of brain imaging affects the assessment of collateral blood flow in patients with blocked arteries in the brain. Researchers found that the best measurements for collateral blood flow, which helps determine how well the brain is being supplied with blood, came from images taken at specific points during a CT Perfusion scan. They discovered strong links between these measurements and the patients' clinical scores, showing that better collateral scores indicate a better condition for the patient, which is crucial for treatment decisions. Who this helps: This helps doctors make better assessments for stroke patients.

PubMed

Open retropubic radical prostatectomy: Still a well-established surgical technique for prostate cancer management.

2023

Actas urologicas espanolas

Stankovic M, Wolff L, Wieder T, Mendes J, Schumacher B +2 more

Plain English
This study looked at the long-term results of open retropubic radical prostatectomy (ORP), a common surgery for prostate cancer, analyzing data from 1,095 patients between 2000 and 2020. The results showed that after 10 years, 73% of patients did not experience a return of cancer, and 82% were still alive; complications occurred in only 4.8% of patients. Additionally, 81.4% were able to control their urine shortly after surgery, and this improved to 89.1% after about a year, highlighting ORP's effectiveness as a reliable treatment option. Who this helps: This helps prostate cancer patients and their doctors in making informed treatment choices.

PubMed

Hemorrhage rates in patients with acute ischemic stroke treated with intravenous alteplase and thrombectomy versus thrombectomy alone.

2023

Journal of neurointerventional surgery

van Kranendonk KR, Kappelhof M, Bruggeman AAE, Rinkel LA, Treurniet KM +12 more

Plain English
This study looked at how different treatments for acute ischemic stroke impact the risk of bleeding in the brain. Among 539 patients, 32% experienced some form of bleeding, with 6% having serious bleeding that could cause symptoms. The findings showed that while using a specific clot-busting treatment (IVT) did not affect overall bleeding rates, it was linked to fewer instances of a certain type of bleeding known as subarachnoid hemorrhage (SAH) when successful blood flow restoration (reperfusion) was achieved. Who this helps: This research benefits doctors treating stroke patients, particularly in deciding on the best treatment approach to minimize risks.

PubMed

Deep reinforcement learning for cerebral anterior vessel tree extraction from 3D CTA images.

2023

Medical image analysis

Su J, Li S, Wolff L, van Zwam W, Niessen WJ +2 more

Plain English
This study focused on creating a new method to identify and extract the major blood vessels in the front part of the brain using 3D images from routine scans. The researchers found that their method could accurately track blood vessels, achieving a 100% overlap with existing standards for nearly all tested vessels and an error of just 1.8 mm. This is important because it can help doctors make better decisions about treatment for patients who have significant blood flow blockages in the brain. Who this helps: Patients with brain blood vessel blockages and their healthcare providers.

PubMed

Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial.

2023

Lancet (London, England)

Olthuis SGH, Pirson FAV, Pinckaers FME, Hinsenveld WH, Nieboer D +58 more

Plain English
This research examined whether endovascular treatment, a procedure to remove blood clots, is beneficial for patients experiencing a specific type of stroke 6 to 24 hours after symptoms start. Out of 535 patients studied, those who received endovascular treatment had a better outcome at 90 days compared to those who did not (a score of 3 versus 4 on a scale measuring disability), but there was a higher rate of bleeding complications in the treatment group (7% vs 2%). These findings are important because they show that, for some stroke patients who may not have been considered for treatment, this procedure can improve recovery chances even later after symptoms begin. Who this helps: This benefits stroke patients who may present late to the hospital.

PubMed

Role of intravenous alteplase on late lesion growth and clinical outcome after stroke treatment.

2023

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Konduri P, Cavalcante F, van Voorst H, Rinkel L, Kappelhof M +12 more

Plain English
This study looked at whether a common stroke treatment called intravenous alteplase (IVT) affects the growth of brain lesions after a stroke. Researchers found that, in a group of 63 patients who received IVT, the average lesion growth was 8.4 milliliters, but IVT did not significantly impact either the presence or the amount of this growth. Growth of these lesions was linked to poorer recovery outcomes, indicating a need for new treatments to prevent lesion growth after strokes. Who this helps: This research benefits doctors and patients by highlighting the need for better post-stroke treatments.

PubMed

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer.

2023

Clinical & experimental metastasis

Wolff L, Steindl A, Popov P, Dieckmann K, Gatterbauer B +5 more

Plain English
This study looked at patients with brain tumors caused by thyroid cancer, which is uncommon. Out of 6,074 patients with thyroid cancer, only 20 were found to have brain metastases, with 10 having follicular and 8 having papillary thyroid cancer. The average survival time after the brain tumors were diagnosed was about 13 months for papillary and 26 months for follicular thyroid cancers, although some patients lived much longer after treatment. Who this helps: This information helps doctors and patients understand the risks and potential outcomes of brain metastases from thyroid cancer.

PubMed

Myositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies: an unusual presentation of graft-versus-host disease.

2023

Leukemia & lymphoma

Wolff L, Clottu A, Mamez AC, Ribi C, Grandoni F

PubMed

Vagally-mediated heart rate variability and depression in children and adolescents - A meta-analytic update.

2023

Journal of affective disorders

Baumeister-Lingens L, Rothe R, Wolff L, Gerlach AL, Koenig J +1 more

Plain English
This study looked at the relationship between heart rate variability and depression in children and adolescents. It found that kids with clinical depression show significantly lower heart rate variability compared to those without depression, with a difference score of about -0.593 on average. However, it did not find a strong link between the severity of depressive symptoms and heart rate variability. This matters because it suggests that monitoring heart rate variability could help identify depression in young people. Who this helps: This helps children and adolescents struggling with depression, as well as the doctors treating them.

PubMed

Does the dose matter? Antiproliferative efficacy and toxicity of everolimus in patients with neuroendocrine tumors - Experiences from a tertiary referral center.

2023

Journal of neuroendocrinology

Kiesewetter B, Melhorn P, Macheiner S, Wolff L, Kretschmer-Chott E +3 more

Plain English
This study looked at how effective and safe the drug everolimus is for treating advanced neuroendocrine tumors (NETs) in 52 patients at a medical center in Vienna. The researchers found that patients with grade 1 NETs had a significantly longer median time without disease worsening (about 42.9 months) compared to those with grade 2 tumors (about 8.9 months). Most patients experienced side effects from the treatment, and nearly half had their doses adjusted due to these issues, but the overall survival rates were similar regardless of the starting dose. Who this helps: This research benefits patients with advanced neuroendocrine tumors and their doctors by providing insights into treatment effectiveness and safety.

PubMed

Histone H1 protects telomeric repeats from H3K27me3 invasion in Arabidopsis.

2023

Cell reports

Teano G, Concia L, Wolff L, Carron L, Biocanin I +16 more

Plain English
This study looked at how a protein called H1 helps manage DNA in Arabidopsis plants. The research found that H1 helps keep certain gene areas organized and prevents the buildup of a chemical marker (H3K27me3) at the ends of chromosomes (telomeres). This matters because maintaining the structure of DNA is essential for proper cell function and aging, similar to processes in mammals. Who this helps: Patients with genetic disorders related to cell aging and stability.

PubMed

Music Engagement as a Source of Cognitive Reserve.

2023

American journal of Alzheimer's disease and other dementias

Wolff L, Quan Y, Perry G, Forde Thompson W

Plain English
This study looked at how participating in music activities can help preserve brain function as people age. Researchers found that lifelong engagement with music can contribute to better cognitive health, especially in older adults who might be at risk for memory loss and other cognitive issues. This is important because as the population ages, finding effective ways to support brain health is becoming increasingly essential. Who this helps: Older adults and their caregivers.

PubMed

Polyarteritis Nodosa: Old Disease, New Etiologies.

2023

International journal of molecular sciences

Wolff L, Horisberger A, Moi L, Karampetsou MP, Comte D

Plain English
This study looks at polyarteritis nodosa (PAN), a rare disease that causes inflammation in blood vessels, mainly affecting medium-sized ones but sometimes smaller ones as well. It often shows vague symptoms like fatigue, fever, and weight loss, and can damage various organs mainly the skin, nerves, and intestines. The authors found that while PAN was once commonly linked to hepatitis B infections, this is less common now, with more cases connected to genetic disorders and cancers. Who this helps: This benefits patients diagnosed with polyarteritis nodosa and their doctors by providing updated information on the disease's causes and effects.

PubMed

Siamese model for collateral score prediction from computed tomography angiography images in acute ischemic stroke.

2023

Frontiers in neuroimaging

Fortunati V, Su J, Wolff L, van Doormaal PJ, Hofmeijer J +5 more

Plain English
This study looked at how to automatically assess the collateral score in stroke patients using CT angiography (CTA) images, which helps doctors decide on treatment options. The researchers found that their new method performed similarly to traditional scoring techniques, showing accuracy within the range of human observers. This is important because having a reliable, automated tool for scoring can make treatment quicker and potentially improve patient outcomes. Who this helps: This helps patients with acute strokes by providing doctors with faster and more accurate assessment tools.

PubMed

Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity.

2022

Frontiers in immunology

Nückel J, Planatscher E, Mohr AW, Deichl K, Mijočević H +13 more

Plain English
Researchers looked at the immune responses of people infected with COVID-19, focusing on specific proteins from the virus and other similar coronaviruses. They found that those with more severe COVID-19 symptoms had higher IgG responses to a protein called nucleocapsid (N), with a significant relationship between severity and the number of viral proteins the immune system targeted. This discovery could help identify patients at higher risk for severe illness early on. Who this helps: This helps doctors better manage and treat patients with COVID-19.

PubMed

Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna.

2022

Therapeutic advances in medical oncology

Melhorn P, Kretschmer-Chott E, Wolff L, Haug A, Mazal P +2 more

Plain English
This study looked at how well different treatments worked for patients with advanced small intestinal neuroendocrine tumors (SI-NETs) at the Medical University of Vienna. Researchers tracked 77 patients for an average of about 82 months and found that, on average, patients lived without the cancer worsening for 32 months after starting treatment. Although the disease can be very serious, the results suggest that the treatments used at this specialized center provide similar outcomes to those seen in major clinical trials. Who this helps: This helps patients with advanced SI-NETs and their doctors by providing real-world data on treatment effectiveness.

PubMed

Prognostic Value of Combined Radiomic Features from Follow-Up DWI and T2-FLAIR in Acute Ischemic Stroke.

2022

Journal of cardiovascular development and disease

Gerbasi A, Konduri P, Tolhuisen M, Cavalcante F, Rinkel L +15 more

Plain English
This study looked at how analyzing brain images can help predict recovery outcomes for patients who have had an acute ischemic stroke, which happens when blood flow to the brain is blocked. Researchers combined data from two types of MRI scans and clinical information, finding that this combination better predicts long-term recovery, with an accuracy rate of about 85%. Understanding these imaging features can help healthcare providers make better predictions about which patients may struggle after a stroke. Who this helps: This benefits patients recovering from strokes and their doctors.

PubMed

Frequent Co-Authors

Barbara Kiesewetter Markus Raderer Wim van Zwam Philipp Melhorn Peter Mazal Aad van der Lugt Clara Bourbousse Fredy Barneche Manon Kappelhof

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.